Aberrant myeloid maturation identified by flow cytometry in primary myelofibrosis

B Feng, S Verstovsek, JL Jorgensen… - American journal of …, 2010 - academic.oup.com
Primary myelofibrosis (PMF) is a myeloproliferative neoplasm that may display a variable
degree of cytopenia and dysplasia sometimes difficult to distinguish from myelodysplastic …

[HTML][HTML] Development of monocytosis in patients with primary myelofibrosis indicates an accelerated phase of the disease

L Boiocchi, R Espinal-Witter, JT Geyer, J Steinhilber… - Modern Pathology, 2013 - Elsevier
Primary myelofibrosis is a type of chronic myeloproliferative neoplasm characterized by
progressive bone marrow failure with worsening cytopenia and in a subset of patients …

Validation of cytogenetic-based risk stratification in primary myelofibrosis

E Rumi, F Passamonti, P Bernasconi… - Blood, The Journal …, 2010 - ashpublications.org
Primary myelofibrosis (PMF) is a Philadelphia chromosome–negative myeloproliferative
neoplasm whose diagnostic criteria have been recently updated. 1 Roughly one-third of the …

How I diagnose primary myelofibrosis

S Prakash, A Orazi - American Journal of Clinical Pathology, 2022 - academic.oup.com
Objectives Primary myelofibrosis (PMF) is a BCR/ABL1-negative myeloproliferative
neoplasm (MPN) with a shorter overall survival and a higher leukemic transformation than …

The implication of identifying JAK2 V617F in myeloproliferative neoplasms and myelodysplastic syndromes with bone marrow fibrosis

RJ Olsen, CH Dunphy, DP O'Malley, L Rice… - Journal of …, 2008 - Springer
The myeloproliferative neoplasms (MPN) and myelodysplastic syndromes (MDS)
occasionally demonstrate overlapping morphological features including hypercellularity …

Discrepancy in diagnosis of primary myelofibrosis between referral and tertiary care centers

CA Yi, G Jeyakumar, P Medina, J Cortes, S Pierce… - Leukemia research, 2014 - Elsevier
Primary myelofibrosis (PMF) is myeloproliferative neoplasm whose diagnosis is based on a
combination of clinical and pathology criteria. We evaluated 560 consecutive patients who …

Value and pitfalls of assessing bone marrow morphologic findings to predict response in patients with myelofibrosis who undergo hematopoietic stem cell …

M Khanlari, X Wang, S Loghavi, SA Wang, S Li… - Annals of Diagnostic …, 2022 - Elsevier
Background Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is a curative
option for patients with myelofibrosis (MF). Bone marrow (BM) morphologic evaluation of …

Unique features of primary myelofibrosis in Chinese

Z Xu, RP Gale, Y Zhang, T Qin, H Chen… - Blood, The Journal …, 2012 - ashpublications.org
Clinical and laboratory features of 642 consecutive Chinese subjects with primary
myelofibrosis (PMF) were analyzed and compared with those of 1054 predominately white …

Identification of patients with poorer survival in primary myelofibrosis based on the burden of JAK2V617F mutated allele

P Guglielmelli, G Barosi, G Specchia… - Blood, The Journal …, 2009 - ashpublications.org
A total of 186 patients with primary myelofibrosis (PMF) were genotyped for JAK2 V617F at
diagnosis aimed at analyzing the correlation of mutational status and mutated allele burden …

Clinical and laboratory features of myelofibrosis and limitations of current therapies.

SA Gregory, RA Mesa, R Hoffman… - Clinical advances in …, 2011 - europepmc.org
Myelofibrosis (MF) is a life-threatening clonal stem cell malignancy characterized by
progressive bone marrow fibrosis and ineffective hematopoiesis. The term" MF" …